Smith & Nephew (SNN)
| Bid | 28.11 |
| Market Cap | 12.41B |
| Revenue (ttm) | 5.81B |
| Net Income (ttm) | 412M |
| EPS (ttm) | 0.94 |
| PE Ratio (ttm) | 30.16 |
| Forward PE | 11.9 |
| Analyst | Hold |
| Ask | 30 |
| Volume | 525,730 |
| Avg. Volume (20D) | 917,300 |
| Open | 28.06 |
| Previous Close | 28.44 |
| Day's Range | 28.02 - 28.46 |
| 52-Week Range | 23.69 - 31.72 |
| Beta | 0.62 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SNN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 week ago · proactiveinvestors.co.uk
Smith & Nephew shares jump 7% on better-than-expected quarterly growthSmith & Nephew PLC (LSE:SN) rose as much as 7% in afternoon trading on Wednesday after the medical technology group reported stronger-than-expected revenue growth in the first quarter of 2025. The Lon...
1 week ago · proactiveinvestors.co.uk
Smith & Nephew jumps as hip and knee replacements in demandSmith & Nephew PLC (LSE:SN) shares rose over 5% to top the early FTSE 100 leaderboard on Wednesday after the knee and hip replacer maintained its full-year 2025 guidance after seeing growth of 3.1% in...
2 months ago · proactiveinvestors.co.uk
Smith & Nephew sees turnaround plan kicking in as profit growsSmith & Nephew PLC has said 2025 should show its transformation plan kicking in despite ongoing woes in China after improving trading over the last year. Revenue climbed 4.7% to US$5.8 billion in the ...